"RPLND is an attractive option for those who prefer to avoid chemotherapy," write Jiping Zeng, MD; Timothy A. Masterson, MD; and Clint Cary, MD, MPH, MBA.
Clint Cary, MD, MBA, MPH
Advertisement
Articles by Clint Cary, MD, MBA, MPH
Advertisement
Latest Updated Articles
The role of surgery continues to evolve in seminomaSeptember 24th 2024
Advertisement
Advertisement
Trending on Urology Times
1
KEYNOTE-B15 data on enfortumab vedotin plus pembrolizumab in MIBC published in NEJM
2
FDA grants priority review to talazoparib plus enzalutamide for HRR gene-altered mCSPC
3
Can Aydogdu, MD on using ctDNA to predict nodal metastases at cystectomy
4
Published data support PSMA-PET–guided selection for 177Lu-rosopatamab tetraxetan in mCRPC
5